Bimekizumab a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

机译：Bimekizumab一种新型人源化IgG1抗体其中和IL-17A和IL-17F

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Frontiers in Immunology
作者
Ralph Adams; Asher Maroof; Terry Baker; Alastair D. G. Lawson; Ruth Oliver; Ross Paveley; Steve Rapecki; Stevan Shaw; Pavan Vajjah; Shauna West; Meryn Griffiths;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类免疫学;
关键词

机译：抗IL-17A;IL-17A;IL-17F;单克隆抗体;Bimekizumab;双重中和;双重针对性;

相似文献

外文文献
中文文献
专利

1. First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis [J] . Glatt Sophie, Helmer Eric, Haier Birgit, British Journal of Clinical Pharmacology . 2017,第5期

机译：Bimekizumab，人源化单克隆抗体和IL-17a和IL-17F的选择性双抑制剂的第一载于人类随机研究，在轻度牛皮癣中
2. First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis [J] . Glatt Sophie, Helmer Eric, Haier Birgit, British Journal of Clinical Pharmacology . 2017,第5期

机译：Bimekizumab，人源化单克隆抗体和IL-17a和IL-17F的选择性双抑制剂的第一载于人类随机研究，在轻度牛皮癣中
3. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation [J] . Glatt Sophie, Baeten Dominique, Baker Terry, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第4期

机译：Bimekizumab在银屑病关节炎中的双IL-17A和IL-17F中和：来自临床前实验的证据和IL-17F有助于人类慢性组织炎症的随机安慰剂对照临床试验
4. Deglycosylation Study of Murine IgG1, IgG2a, IgG2b, and Humanized IgG1 Monoclonal Antibodies [C] . Megan Ellis, John Lambert, Alexandru C. Lazar American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：鼠IgG1，IgG2a，IgG2b和人源化IgG1单克隆抗体的脱糖基化研究
5. Development and characterization of a neutralizing chimeric murine-human IgG1/kappa monoclonal antibody to the protective antigen toxin of Bacillus anthracis. [D] . Boese, Darren Jacob. 2009

机译：抗炭疽芽孢杆菌保护性抗原毒素的中和嵌合鼠-人IgG1 / kappa单克隆抗体的开发和表征。
6. Extended report: Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation [O] . Sophie Glatt, Dominique Baeten, Terry Baker, -1

机译：扩展报告：Bimekizumab在银屑病关节炎中对IL-17A和IL-17F的双重中和作用：来自临床前实验和随机安慰剂对照临床试验的证据表明IL-17F有助于人类慢性组织炎症
7. 699 Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution to immune-mediated inflammatory skin response [O] . A. Maroof, T. Smallie, S. Archer, 2017

机译：699双IL-17A和IL-17F抑制与Bimekizumab提供了对免疫介导的炎症皮肤反应的IL-17F贡献的证据

Bimekizumab a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

著录项

引文网络

相似文献

相关主题

期刊订阅